CCL5 and neoplasm: In our study, CCL5 and CXCL10 were more highly expressed in cancerous tissues than in marginal sites; the chemokines' expression was not affected by patients' age, gender, tumor differentiation, or clinical TNM stages, except that CCL5 was further upregulated in clinical T3-T4 stages (Table 1).